This is a demo store. No orders will be fulfilled.
Healthcare
Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.
Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum
-
01 Mar 2022  |  Europe
European Clinical Laboratory Services Growth Opportunity
Customer Experience Driven by New B2B and B2C Business Models
Diagnostics is the backbone of the healthcare sector. According to a World Health Organization (WHO) study, although the segment accounts for less than 5% of hospital costs, its findings influence 60–70% of healthcare decision-making. Diagnostics helps to analyze medical conditions and guide patients toward the right medication, treatment, or sur...
$2,450.00 -
31 Jan 2022  |  Asia Pacific
Enterprise Imaging Partnerships and Growth Opportunities in Selected Asia-Pacific Countries
New Business Models Overcome Budget Restrictions to Enable Equipment Purchase and Management
In this report, Frost & Sullivan analyzes emerging business models in the medical imaging industry in Asia-Pacific, focusing on India, Australia, Vietnam, Indonesia, and Singapore. Conventional business models that focus on selling products based on specification superiority or unique selling propositions are forecast to slow down. Requirement chan...
$2,450.00 -
26 Nov 2021  |  Europe
EU COVID-19 Vaccine and Therapeutics Insights, Trends, and Growth Opportunities
Future Growth Potential Driven by Capabilities and Expertise in Vaccine Manufacturing
With this research service, Frost & Sullivan’s Healthcare and Life Sciences team provides critical insights into the European Union and UK COVID-19 vaccine and therapeutics market. The report analyzes COVID-19 vaccines and therapeutics in development and delves into supply chain considerations and requirements to manage distribution. Importantly,...
$2,450.00 -
22 Mar 2021  |  Europe
Impact of COVID-19 on Elective Procedures in Western Europe, 2020–2023
Growth Strategies to Navigate the Uncertainty Surrounding Elective Procedure Deferrals and Their Impact on the Medical Device Market
The deferral of elective procedures due to pandemic-related measures has adversely affected the cardiovascular medical devices market. While some cardiovascular procedures are considered urgent, others have been rescheduled and deferred. Nearly 80% of all the orthopedic procedures performed in Europe are estimated to have been delayed, postponed,...
$4,950.00 -
11 Feb 2021  |  Europe
Innovative Business Models Powering the Telehealth Market in Europe
Expansion in Consumer Health and Improved Access to Care Spur New Growth Opportunities
As the rapid spread and impact of COVID-19 continue to cripple healthcare sector providers across Europe, telehealth is emerging as a boon in ensuring efficient access to essential healthcare services. Primary care appointments took a major downturn as people avoided them largely until necessary or were unable to have routine face-to-face visits du...
$4,950.00 -
30 Nov 2020  |  Europe
Investment in Genomics, Advanced Therapies, and Precision Health Offers New Opportunities for the UK MedTech Market
Innovation Culture in the Life Sciences Sector Enables Growth Despite the Short-term Impact of COVID-19 and Brexit
The United Kingdom (UK) medical technology (MedTech) market is experiencing a transformational phase. Although it achieved steady growth up to 2019 and was infused with investments as part of the UK Life Sciences Sector Deal, market and regulatory challenges persist. In this research study, Frost & Sullivan analyzes the UK MedTech market landscape ...
$4,950.00 -
10 Sep 2020  |  Europe
Rising EHR Adoption and ICD-10 Implementation Transforming the Computer Assisted Coding Market in Select European Countries, 2020
The Focus on Improving Documentation Efficiency and Achieving Maximum Reimbursement Drives Growth Opportunities
Clinical documentation using the electronic medical record (EMR) is the base for performing coding. Coding is predominantly done through manual work performed by a combination of coding/data management teams enabled by EMR, with few hospitals investing in specialized computer assisted coding (CAC) solutions. Majority of the hospitals are aware of t...
$4,950.00 -
26 Feb 2020  |  Europe
Growth Opportunities from the Evolution of Electronic Health Record (EHR) in Europe, Forecast to 2024
Actionable Strategies and Tactics to Accelerate Growth in a Transforming Market
The healthcare IT landscape is witnessing rapid transformation as governments focus more on value-based care and preventive health programs to reduce the overall economic burden on health systems, along with increased efficiency in managing increasing patient populations. The basic Electronic Medical Record (EMR) is evolving into a more comprehensi...
$4,950.00 -
06 Jun 2018  |  Asia Pacific
Growth Opportunities in the Asia-Pacific Population Health Management Solutions Market, Forecast to 2022
Coordinated Advances in Efficiency and Quality Depend on Collaborative Ecosystems
Population Health Management (PHM) has many connotations ranging from an ideal or a concept to a real market segment. As a concept it refers to the reduction of disease risk and the attached financial burden at a population level. Execution of the concept entails intricate interaction between telehealth technologies, software solutions, and healthc...
$3,000.00 -
10 Jan 2018  |  Asia Pacific
APAC Biosimilar Market, Forecast 2025
Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth
Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Ko...
$4,950.00